|
Volumn 14, Issue 5, 2010, Pages
|
Withholding selective decontamination of the digestive tract from critically ill patients must now surely be ethically questionable given the vast evidence base
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBAPENEM;
CEFTAZIDIME;
CEPHALOSPORIN;
CIPROFLOXACIN;
PENICILLIN G;
QUINOLONE;
TOBRAMYCIN;
ANTIBIOTIC THERAPY;
BACTERIUM CONTAMINATION;
CONTROLLED CLINICAL TRIAL (TOPIC);
DIGESTIVE SYSTEM;
DISINFECTION;
GASTROINTESTINAL INFECTION;
GRAM NEGATIVE BACTERIUM;
GRAM NEGATIVE INFECTION;
HUMAN;
INTERMETHOD COMPARISON;
LETTER;
LOWER RESPIRATORY TRACT INFECTION;
MULTIDRUG RESISTANCE;
PRIORITY JOURNAL;
SELECTIVE DIGESTIVE DECONTAMINATION;
SELECTIVE OROPHARYNGEAL DECONTAMINATION;
CRITICAL ILLNESS;
ETHICS;
EVIDENCE BASED MEDICINE;
GASTROINTESTINAL TRACT;
MICROBIOLOGY;
NOTE;
TREATMENT WITHDRAWAL;
WASTE MANAGEMENT;
CRITICAL ILLNESS;
DECONTAMINATION;
EVIDENCE-BASED MEDICINE;
GASTROINTESTINAL TRACT;
HUMANS;
WITHHOLDING TREATMENT;
|
EID: 77957291609
PISSN: 13648535
EISSN: 1466609X
Source Type: Journal
DOI: 10.1186/cc9255 Document Type: Letter |
Times cited : (7)
|
References (5)
|